156 related articles for article (PubMed ID: 6603034)
1. C1q and immune complexes in liver cirrhosis sera.
Yoshida H; Sato M; Watanabe S; Nishimaki T; Morito T; Kasukawa R; Nakai M
Tohoku J Exp Med; 1983 May; 140(1):73-9. PubMed ID: 6603034
[TBL] [Abstract][Full Text] [Related]
2. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
Antes U; Heinz HP; Loos M
J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
[TBL] [Abstract][Full Text] [Related]
3. Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia.
Agnello V; Mitamura T
Clin Immunol Immunopathol; 1987 Mar; 42(3):338-43. PubMed ID: 3493866
[TBL] [Abstract][Full Text] [Related]
4. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
5. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
Greisman SG; Redecha PB; Kimberly RP; Christian CL
J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
Antes U; Heinz HP; Loos M
Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
[TBL] [Abstract][Full Text] [Related]
7. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
8. Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus.
Wener MH; Mannik M; Schwartz MM; Lewis EJ
Medicine (Baltimore); 1987 Mar; 66(2):85-97. PubMed ID: 3102894
[TBL] [Abstract][Full Text] [Related]
9. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
[TBL] [Abstract][Full Text] [Related]
10. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis.
Roberts JL; Wyatt RJ; Schwartz MM; Lewis EJ
Clin Immunol Immunopathol; 1983 Nov; 29(2):223-41. PubMed ID: 6605223
[TBL] [Abstract][Full Text] [Related]
11. Nonparticipation of C1q in the decrease of complement activity in the cold in sera of patients with chronic liver diseases.
Yoshida H; Morito T; Onizawa N; Kasukawa R
Int Arch Allergy Appl Immunol; 1980; 62(4):433-41. PubMed ID: 6247290
[TBL] [Abstract][Full Text] [Related]
12. Effects of single-stranded DNA on circulating immune complexes in SLE sera detected by C1q solid-phase assay.
Furukawa F; Sekita K; Muso E; Imamura S; Hamashima Y
Arch Dermatol Res; 1985; 277(1):71-4. PubMed ID: 3871602
[No Abstract] [Full Text] [Related]
13. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
14. C1q solid-phase radioimmunoassay: binding properties of solid-phase C1q and evidence that C1q-binding IgG complexes in systemic lupus erythematosus are not bound to endogenous C1q.
Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
J Immunol Methods; 1984 Oct; 73(1):67-74. PubMed ID: 6436382
[TBL] [Abstract][Full Text] [Related]
15. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus.
Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
Clin Immunol Immunopathol; 1984 Jan; 30(1):104-16. PubMed ID: 6421520
[TBL] [Abstract][Full Text] [Related]
16. Studies on circulating soluble immune complexes of the liver disease. 7. Immune complexes in the clinical course and their ultracentrifugal analysis.
Narumoto J
Gastroenterol Jpn; 1981; 16(2):186-92. PubMed ID: 6262181
[TBL] [Abstract][Full Text] [Related]
17. Reduced opsonisation of protein A containing Staphylococcus aureus in sera with cryoglobulins from patients with active systemic lupus erythematosus.
Nived O; Linder C; Odeberg H; Svensson B
Ann Rheum Dis; 1985 Apr; 44(4):252-9. PubMed ID: 3872638
[TBL] [Abstract][Full Text] [Related]
18. Evidence against an immune complex pathogenesis of primary biliary cirrhosis.
Goldberg MJ; Kaplan MM; Mitamura T; Anderson CL; Matloff DS; Pinn VW; Agnello V
Gastroenterology; 1982 Sep; 83(3):677-83. PubMed ID: 6212278
[No Abstract] [Full Text] [Related]
19. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
Larsson A; Sjöquist J
J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight C1q in systemic lupus erythematosus.
Hoekzema R; Hannema AJ; Swaak TJ; Paardekooper J; Hack CE
J Immunol; 1985 Jul; 135(1):265-71. PubMed ID: 3923103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
